Business Context and Reporting Period
Company: Zimmer Holdings, Inc. (Note: Metadata lists Zimmer Biomet Holdings, Inc., but filing text specifies Zimmer Holdings, Inc.)
Filing Type: Form 8-K (Current Report)
Date of Report: October 25, 2006
Reporting Period: Quarter ended September 30, 2006
This filing reports the results of operations for the quarter ended September 30, 2006. The detailed earnings release is attached as Exhibit 99.1 and incorporated by reference.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are contained within the attached press release (Exhibit 99.1).
The company reports the following non-GAAP financial measures in the attached release:
- Adjusted net earnings
- Adjusted diluted EPS and projected adjusted diluted EPS
- Adjusted net margin, adjusted operating margin, and adjusted gross margin
- Constant currency sales
These measures exclude acquisition and integration expenses, inventory step-up, and the effects of share-based payment under SFAS 123(R) to enhance comparability with prior periods.
Material Changes and Accounting Adjustments
The filing highlights several material accounting and operational contexts affecting the reported period:
- Acquisitions: Results reflect the integration of Centerpulse AG (acquired October 2, 2003) and Implex Corp. (acquired April 23, 2004).
- Share-Based Payment: Financial results include the adoption of SFAS No. 123 (revised 2004). The company provides adjusted non-GAAP measures excluding this impact to allow comparison with prior periods that did not include SFAS 123(R).
- Currency Impact: Sales performance is reported using "constant currency sales" to exclude the effects of foreign currency exchange rate fluctuations.
Guidance, Outlook, and Risks
Management Commentary: Management states that the presentation of non-GAAP measures aids investors in understanding operating results absent specific acquisition-related items and SFAS 123(R) effects. These measures are intended to facilitate period-to-period comparisons.
Limitations: The filing explicitly states that non-GAAP measures should be considered in addition to, and not as a substitute for, GAAP measures. All non-GAAP measures are reconciled to GAAP in the press release.
Legal Status: The information furnished in this report is not deemed "filed" with the SEC and is not incorporated by reference into other SEC filings. The registrant makes no admission as to the materiality of the information.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific numerical values on revenue, earnings, and margins.
- Verify the reconciliation between reported non-GAAP measures and GAAP financial measures.
- Assess the specific impact of SFAS 123(R) share-based payments on net income.
- Confirm the magnitude of acquisition and integration expenses excluded from adjusted earnings.
- Check the constant currency sales calculation methodology for comparability with peers.